miR‑1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer

Yuqing Pei1, Kexin Li1, Xiaoying Lou1

  • 1State Key Laboratory of Molecular Oncology, Department of Clinical Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China.

Oncology Reports
|May 30, 2020
PubMed

Insights

MicroRNA-1299 (miR-1299) inhibits ovarian cancer (OC) progression by downregulating NOTCH3. This study reveals a miR-1299/NOTCH3/TUG1 feedback loop, offering potential therapeutic targets for OC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Notch receptor 3 (NOTCH3) plays an oncogenic role in ovarian cancer (OC).
  • The precise regulatory mechanisms of NOTCH3 in OC pathogenesis require further elucidation.
  • Identifying novel regulators and pathways is crucial for developing targeted therapies.

Purpose of the Study:

  • To identify microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) that regulate NOTCH3 in OC.
  • To investigate the functional role of identified regulators in OC cell proliferation and tumor growth.
  • To explore the underlying molecular mechanisms, including potential feedback loops, involving NOTCH3, miRNAs, and lncRNAs in OC.

Main Methods:

  • Bioinformatics analysis and luciferase reporter assays to identify regulatory miRNAs and lncRNAs.
  • In vitro assays (cell proliferation, colony formation, EdU incorporation, cell cycle analysis) to assess functional effects.
  • In vivo xenograft mouse models to evaluate tumor growth suppression.

Main Results:

  • MicroRNA-1299 (miR-1299) was identified as a direct negative regulator of NOTCH3, downregulated in OC.
  • Overexpression of miR-1299 inhibited OC cell proliferation, colony formation, and induced G0G1 cell cycle arrest, suppressing tumor growth in vivo.
  • Long non-coding RNA taurine upregulated gene 1 (TUG1) acts as a sponge for miR-1299, upregulating NOTCH3 and promoting proliferation.
  • A feedback loop involving miR-1299, NOTCH3, and TUG1 was identified in OC development.

Conclusions:

  • miR-1299 functions as a tumor suppressor in OC by targeting NOTCH3.
  • The lncRNA TUG1 promotes OC progression via the competing endogenous RNA mechanism involving miR-1299 and NOTCH3.
  • The identified miR-1299/NOTCH3/TUG1 feedback loop provides novel insights into OC pathogenesis and potential therapeutic strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.2K